Limited Competition: Data Coordinating Center for Type 1 Diabetes TrialNet (UC4)

The summary for the Limited Competition: Data Coordinating Center for Type 1 Diabetes TrialNet (UC4) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Limited Competition: Data Coordinating Center for Type 1 Diabetes TrialNet (UC4): This Funding Opportunity Announcement (FOA) invites an application from the Program Director/Principal Investigator of the Data Coordinating Center (DCC) that is currently supporting the research being performed by the complex and effective Type 1 Diabetes TrialNet network. This FOA will support the design and conduct of new-onset trials (as selected by the TrialNet Steering Committee) aimed at preservation of insulin-producing cells in individuals with new-onset diabetes. The DCC will support a wide range of research projects in varying stages of development, implementation and completion. The DCC will provide for data and sample management, including standardized acquisition, quality control, dissemination, and public accessibility.

Federal Grant Title:	Limited Competition: Data Coordinating Center for Type 1 Diabetes TrialNet (UC4)
Federal Agency Name:	National Institutes of Health (HHS-NIH11)
Grant Categories:	Food and Nutrition Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-DK-16-505
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.847, 93.855, 93.856
CFDA Descriptions:	Information not provided
Current Application Deadline:	March 14th, 2017
Original Application Deadline:	March 14th, 2017
Posted Date:	December 5th, 2016
Creation Date:	December 5th, 2016
Archive Date:	April 14th, 2017
Total Program Funding:	$50,000,000
Maximum Federal Grant Award:	$45,000,000
Minimum Federal Grant Award:
Expected Number of Awards:	1
Cost Sharing or Matching:	No
Last Updated:	December 5th, 2016

Applicants Eligible for this Grant: Public and State controlled institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. See FOA for eligibility details.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-16-505.html
Grant Announcement Contact: NIH OER Webmaster
[email protected]

If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants: • Kidney Technology Development Research Education Program (R25 - Independent Clinical Trial...; • Adaptation of Diabetes Control Technologies for Older Adults with T1D (R01 Clinical Trial...; • Discovery of Early Type 1 Diabetes Disease Processes in the Human Pancreas [HIRN Consortiu...; • Diabetes Research Centers (P30 Clinical Trial Optional); • Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogen...; • Proteomic and Metabolomic Approaches to Diagnose Diabetes and Pre-Diabetes; • Molecular Therapy Core Centers; • Pilot and Feasibility Program in Human Islet Biology
More Grants from the National Institutes of Health: • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...; • HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggabl...; • Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical T...; • Global Infectious Disease Research Training Program (D43 Clinical Trial Optional); • Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance U...